Protein kinase C–associated kinase is required for NF-κB signaling and survival in diffuse large B-cell lymphoma cells

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Blood

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2007-05-088591
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway.

  2007cited by this paper
• Targeting BAFF: immunomodulation for autoimmune diseases and lymphomas.

  2006cited by this paper
• Treatment of diffuse large B-cell lymphomas.

  2006cited by this paper
• IkappaB kinase complexes: gateways to NF-kappaB activation and transcription.

  2006cited by this paper
• BAFF, APRIL and their receptors: structure, function and signaling.

  2006cited by this paper
• Protein kinase C-associated kinase is not required for the development of peripheral B lymphocyte populations.

  2006cited by this paper
• NF-kappaB and cancer: mechanisms and targets.

  2006cited by this paper
• NF‐κB and cancer: Mechanisms and targets

  2006cited by this paper
• Constitutive NF-κB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas

  2006cited by this paper
• NF-κB and IKK as therapeutic targets in cancer

  2006cited by this paper
• Nuclear factor-kappaB in cancer development and progression.

  2006cited by this paper
• NF-kappaB and IKK as therapeutic targets in cancer.

  2006cited by this paper
• B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia.

  2006cited by this paper
• Chemotherapy dose intensity in non-Hodgkin's lymphoma: is dose intensity an emerging paradigm for better outcomes?

  2005cited by this paper
• Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha.

  2005cited by this paper
• The RIP kinases: crucial integrators of cellular stress.

  2005cited by this paper
• Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling.

  2005cited by this paper
• Inflammation-associated cancer: NF-kappaB is the lynchpin.

  2005cited by this paper
• IKK/NF-κB signaling: balancing life and death – a new approach to cancer therapy

  2005cited by this paper
• Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach.

  2005cited by this paper
• The biology of human lymphoid malignancies revealed by gene expression profiling.

  2005cited by this paper
• The role of APRIL and BAFF in lymphocyte activation.

  2005cited by this paper
• NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes.

  2005cited by this paper
• State-of-the-art therapeutics: diffuse large B-cell lymphoma.

  2005cited by this paper
• Inflammation-associated cancer: NF-κB is the lynchpin

  2005cited by this paper
• Small molecule inhibitors of IκB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling

  2005cited by this paper
• IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy.

  2005cited by this paper
• The IKK NF-κB system: a treasure trove for drug development

  2004cited by this paper
• The IKK NF-kappa B system: a treasure trove for drug development.

  2004cited by this paper
• The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers.

  2004cited by this paper
• Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway.

  2004cited by this paper
• Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome.

  2004cited by this paper
• DNA damage induces downregulation of histone gene expression through the G1 checkpoint pathway

  2004cited by this paper
• Signaling to NF-kappaB.

  2004cited by this paper
• NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells.

  2003cited by this paper
• Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin's lymphoma.

  2003cited by this paper
• NF-κB1 p50 Is Required for BLyS Attenuation of Apoptosis but Dispensable for Processing of NF-κB2 p100 to p52 in Quiescent Mature B Cells1

  2003cited by this paper
• The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

  2003cited by this paper
• A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

  2003cited by this paper
• Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy.

  2003cited by this paper
• Protein Kinase C-associated Kinase Can Activate NFκB in Both a Kinase-dependent and a Kinase-independent Manner*

  2003cited by this paper
• Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

  2003cited by this paper
• Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival.

  2002cited by this paper
• Protein Kinase C-associated Kinase (PKK) Mediates Bcl10-independent NF-κB Activation Induced by Phorbol Ester*

  2002cited by this paper
• RIP4 (DIK/PKK), a novel member of the RIP kinase family, activates NF‐κB and is processed during apoptosis

  2002cited by this paper
• RIP4 is an ankyrin repeat-containing kinase essential for keratinocyte differentiation.

  2002cited by this paper
• Molecular diagnosis of lymphoid malignancies by gene expression profiling.

  2002cited by this paper
• BLyS and BLyS receptor expression in non-Hodgkin's lymphoma.

  2002cited by this paper
• BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells.

  2002cited by this paper
• BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.

  2002cited by this paper
• IKKalpha controls formation of the epidermis independently of NF-kappaB.

  2001cited by this paper
• IKKα controls formation of the epidermis independently of NF-κB

  2001cited by this paper
• Transcription of the RelB gene is regulated by NF-kappaB.

  2001cited by this paper
• Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma Cells

  2001cited by this paper
• Protein Kinase C-associated Kinase (PKK), a Novel Membrane-associated, Ankyrin Repeat-containing Protein Kinase*

  2001cited by this paper
• Annexin V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis

  2000cited by this paper
• DIK, a Novel Protein Kinase That Interacts with Protein Kinase Cδ

  2000cited by this paper
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

  2000cited by this paper
• Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis.

  1999cited by this paper
• Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation.

  1999cited by this paper
• The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis

  1999cited by this paper
• The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis.

  1999cited by this paper
• Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation

  1999cited by this paper
• Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry.

  1998cited by this paper
• NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176

  1998cited by this paper
• NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176.

  1998cited by this paper
• Structural and functional characterization of the promoter regions of the NFKB2 gene.

  1995cited by this paper
• A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V.

  1995cited by this paper
• Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

  1995cited by this paper
• Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE

  1994cited by this paper
• Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.

  1993cited by this paper
• Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production.

  1991cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper

• Functions of the RIP kinase family members in the skin

  2023cites this paper
• NF-κB Signaling Pathway and Efficacy of Bortezomib-Based Combination Chemotherapy in Patients with Non-Hodgkin's Lymphoma

  2022cites this paper
• DLBCL 1L—What to Expect beyond R-CHOP?

  2022cites this paper
• Depletion of RIPK4 parallels higher malignancy potential in cutaneous squamous cell carcinoma

  2022cites this paper
• Insight Into the Function of RIPK4 in Keratinocyte Differentiation and Carcinogenesis

  2020cites this paper
• Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes

  2019cites this paper
• RIPK4 activity in keratinocytes is controlled by the SCFβ-TrCP ubiquitin ligase to maintain cortical actin organization

  2018cites this paper
• PKK deletion in basal keratinocytes promotes tumorigenesis after chemical carcinogenesis

  2018cites this paper
• RIPK4 promotes bladder urothelial carcinoma cell aggressiveness by upregulating VEGF-A through the NF-κB pathway

  2018cites this paper
• RIP4 inhibits STAT3 signaling to sustain lung adenocarcinoma differentiation

  2017cites this paper
• NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.

  2017cites this paper
• PKK deficiency in B cells prevents lupus development in Sle lupus mice.

  2017cites this paper
• Theranostic Approaches for Pathway-Activated Systems in Oncology

  2017cites this paper
• A critical role for the protein kinase PKK in the maintenance of recirculating mature B cells and the development of B1 cells.

  2016cites this paper
• Chemotherapy‐mediated pain and peripheral neuropathy: impact of oxidative stress and inflammation

  2016cites this paper
• Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline

  2015cites this paper
• Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifies RIPK4 as novel tumor suppressor in human hepatocarcinogenesis

  2014cites this paper
• PKK Suppresses Tumor Growth and is Decreased in Squamous Cell Carcinoma of the Skin

  2014cites this paper
• Diffuse large B-cell lymphoma—treatment approaches in the molecular era

  2014cites this paper
• Protein kinase C-associated kinase regulates NF-κB activation through inducing IKK activation.

  2014cites this paper
• The mechanism underlying the effects of the cell surface ATP synthase on the regulation of intracellular acidification during acidosis

  2013cites this paper
• Nanodisk: a versatile drug delivery platform

  2012cites this paper
• Cross-Talk between NFkB and the PI3-Kinase/AKT Pathway Can Be Targeted in Primary Effusion Lymphoma (PEL) Cell Lines for Efficient Apoptosis

  2012cites this paper
• Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A.

  2012cites this paper
• Reciprocal Inhibition between the Transforming Growth Factor-β-activated Kinase 1 (TAK1) and Apoptosis Signal-regulating Kinase 1 (ASK1) Mitogen-activated Protein Kinase Kinase Kinases and Its Suppression by TAK1-binding Protein 2 (TAB2), an Adapter Protein for TAK1*

  2011cites this paper
• An increase in B cell apoptosis by interfering BAFF-BAFF-R interaction with small synthetic molecules.

  2011cites this paper
• ROS/Epac1-mediated Rap1/NF-kappaB activation is required for the expression of BAFF in Raw264.7 murine macrophages.

  2011cites this paper
• Applikation der retroviralen Insertionsmutagenese zur Identifikation relevanter molekularer Mechanismen in der humanen Hepatokarzinogenese

  2011cites this paper
• Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways.

  2011cites this paper
• Curcumin nanodisk-induced apoptosis in mantle cell lymphoma

  2011cites this paper
• Curcumin suppresses constitutive activation of nuclear factor-κB and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines

  2008cites this paper
• Rapamycin reverses TLR4 signaling-triggered tumor apoptosis resistance by disrupting Akt-mediated Bcl-xL upregulation.

  2008cites this paper
• The role of NF‐κB in lymphoid malignancies

  2008cites this paper